Your browser doesn't support javascript.
loading
Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
Montal, Victor; Vilaplana, Eduard; Pegueroles, Jordi; Bejanin, Alexandre; Alcolea, Daniel; Carmona-Iragui, María; Clarimón, Jordi; Levin, Johannes; Cruchaga, Carlos; Graff-Radford, Neill R; Noble, James M; Lee, Jae-Hong; Allegri, Ricardo; Karch, Celeste M; Laske, Christoph; Schofield, Peter R; Salloway, Stephen; Ances, Beau; Benzinger, Tammie; McDale, Eric; Bateman, Randall; Blesa, Rafael; Sánchez-Valle, Raquel; Lleó, Alberto; Fortea, Juan.
Afiliación
  • Montal V; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Vilaplana E; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Pegueroles J; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bejanin A; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Carmona-Iragui M; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Clarimón J; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Levin J; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Cruchaga C; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Graff-Radford NR; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Noble JM; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Lee JH; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Allegri R; Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain.
  • Karch CM; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Laske C; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Schofield PR; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Salloway S; German Center for Neurodegenerative Diseases, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Ances B; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Benzinger T; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • McDale E; The Hope Center for Neurological Disorders, St. Louis, Missouri, USA.
  • Bateman R; NeuroGenomics and Informatics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Blesa R; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Sánchez-Valle R; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Lleó A; Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
  • Fortea J; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Alzheimers Dement ; 17(4): 618-628, 2021 04.
Article en En | MEDLINE | ID: mdl-33196147
ABSTRACT

INTRODUCTION:

A biphasic model for brain structural changes in preclinical Alzheimer's disease (AD) could reconcile some conflicting and paradoxical findings in observational studies and anti-amyloid clinical trials.

METHODS:

In this study we tested this model fitting linear versus quadratic trajectories and computed the timing of the inflection points vertexwise of cortical thickness and cortical diffusivity-a novel marker of cortical microstructure-changes in 389 participants from the Dominantly Inherited Alzheimer Network.

RESULTS:

In early preclinical AD, between 20 and 15 years before estimated symptom onset, we found increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later preclinical and symptomatic stages. The inflection points 16 to 19 years before estimated symptom onset are in agreement with the start of tau biomarker alterations.

DISCUSSION:

These findings confirm a biphasic trajectory for brain structural changes and have direct implications when interpreting magnetic resonance imaging measures in preventive AD clinical trials.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Corteza Cerebral / Enfermedad de Alzheimer / Síntomas Prodrómicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Alzheimers Dement Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Corteza Cerebral / Enfermedad de Alzheimer / Síntomas Prodrómicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Alzheimers Dement Año: 2021 Tipo del documento: Article País de afiliación: España